United States Surgical Equipment Medical Equipment Industry Report
Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Surgical Sutures, Hand Instruments and Electrosurgical Equipment and Supplies

United States Surgical Equipment Medical Equipment Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Surgical Sutures, Hand Instruments and Electrosurgical Equipment and Supplies

United States Surgical Equipment Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to United States surgical equipment medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the surgical equipment medical equipment in United States.

Scope

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

• 1 Table Of Contents
  • 1.1 1.2 2 Introduction
  • 2.1 What Is This Report About?
  • 2.2 Definitions
    • 2.2.1 Surgical Equipment
• 3 Healthcare Sector Review
  • 3.1 Healthcare Expenditure
  • 3.2 Healthcare Infrastructure
    • 3.2.1 Healthcare Personnel Data
    • 3.2.2 Healthcare Facilities Data
• 4 Surgical Equipment in United States
  • 4.1 Surgical Equipment Overall Revenues (2000-2012)
  • 4.2 Surgical Equipment Overall Volume (2000-2012)
  • 4.3 Surgical Equipment Overall Company Shares (2005-2006)
• 5 Surgical Sutures in United States
  • 5.1 Surgical Sutures Overall Revenues (2000-2012)
    • 5.1.1 Absorbable Sutures Overall Revenues (2000-2012)
    • 5.1.2 Non Absorbable Sutures Overall Revenues (2000-2012)
  • 5.2 Surgical Sutures Overall Volume (2000-2012)
    • 5.2.1 Absorbable Sutures Overall Volume (2000-2012)
    • 5.2.2 Non Absorbable Sutures Overall Volume (2000-2012)
  • 5.3 Surgical Sutures Average Price (2000-2012)
    • 5.3.1 Absorbable Sutures Average Price (2000-2012)
    • 5.3.2 Non Absorbable Sutures Average Price (2000-2012)
  • 5.4 Surgical Sutures Distribution Share (2005-2006)
  • 5.5 Surgical Sutures Company Share (2005-2006)
• 6 Hand Instruments in United States
  • 6.1 Hand Instruments Overall Revenues (2000-2012)
  • 6.2 Hand Instruments Overall Volume (2000-2012)
  • 6.3 Hand Instruments Average Price (2000-2012)
  • 6.4 Hand Instruments Distribution Share (2005-2006)
  • 6.5 Hand Instruments Company Share (2005-2006)
• 7 Electrosurgical Devices in United States
  • 7.1 Electrosurgical Devices Overall Revenues (2000-2012)
    • 7.1.1 Electrosurgical Disposables and Accessories Overall Revenues (2000-2012)
    • 7.1.2 Electrosurgical Generator Overall Revenues (2000-2012)
  • 7.2 Electrosurgical Devices Overall Volume (2000-2012)
    • 7.2.1 Electrosurgical Disposables and Accessories Overall Volume (2000-2012)
    • 7.2.2 Electrosurgical Generator Overall Volume (2000-2012)
  • 7.3 Electrosurgical Devices Average Price (2000-2012)
    • 7.3.1 Electrosurgical Generator Average Price (2000-2012)
    • 7.3.2 Electrosurgical Disposables and Accessories Average Price (2000-2012)
  • 7.4 Electrosurgical Devices Distribution Share (2005-2006)
  • 7.5 Electrosurgical Devices Company Share (2005-2006)
• 8 Ethicon, Inc. Company Profile
  • 8.1 Company Overview
  • 8.2 Business Overview
    • 8.2.1 Major Products and Services
  • 8.3 Locations And Subsidiaries
  • 8.4 Financial Deals Landscape
    • 8.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON
    • 8.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON
    • 8.4.3 ETHICON Acquires Vascular Control Systems
    • 8.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON
• 9 Covidien Ltd./Tyco Healthcare Company Profile
  • 9.1 Company Overview
  • 9.2 Business Overview
    • 9.2.1 Imaging Solutions
    • 9.2.2 Medical Devices
    • 9.2.3 Medical Supplies
    • 9.2.4 Pharmaceutical Products
    • 9.2.5 Retail Products
    • 9.2.6 Major Products and Services
    • 9.2.7 History
  • 9.3 Value Chain Analysis
    • 9.3.1 Manufacturing
    • 9.3.2 Product Development
    • 9.3.3 Sales and Marketing
  • 9.4 SWOT Analysis
    • 9.4.1 Covidien Ltd./Tyco Healthcare Strengths
    • 9.4.2 Covidien Ltd./Tyco Healthcare Weaknesses
    • 9.4.3 Covidien Ltd./Tyco Healthcare Opportunities
    • 9.4.4 Covidien Ltd./Tyco Healthcare Threats
  • 9.5 Financial and Operational Review
    • 9.5.1 Financial Statements
    • 9.5.2 Financial Ratios
    • 9.5.3 Share Holding Structure
  • 9.6 Locations And Subsidiaries
  • 9.7 Financial Deals Landscape
    • 9.7.1 Covidien Signs An Agreement With Allergan
    • 9.7.2 Covidien Acquires Scandius Biomedical
    • 9.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million
    • 9.7.4 Covidien And BioSynthema Enter Into Licensing Agreement
    • 9.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien
    • 9.7.6 Covidien To Sell European Incontinence Business
    • 9.7.7 Covidien To Acquire Tissue Science Laboratories
  • 9.8 Recent Developments
    • 9.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007
    • 9.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend
    • 9.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case
    • 9.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results
    • 9.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend
    • 9.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results
    • 9.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results
    • 9.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent
    • 9.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend
    • 9.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results
  • 9.9 Covidien Ltd./Tyco Healthcare Pipeline Products
    • 9.9.1 PleuraSeal Lung Sealant System
    • 9.9.2 Sandman Intro CPAP Device
• 10 B. Braun Melsungen AG Company Profile
  • 10.1 Company Overview
  • 10.2 Business Overview
    • 10.2.1 Aesculap division
    • 10.2.2 B. Braun Avitum division
    • 10.2.3 Hospital Care division
    • 10.2.4 Out Patient Market (OPM) division
    • 10.2.5 Major Products and Services
    • 10.2.6 History
  • 10.3 Value Chain Analysis
    • 10.3.1 Manufacturing
    • 10.3.2 Product Development
    • 10.3.3 Sales and Marketing
  • 10.4 SWOT Analysis
    • 10.4.1 B. Braun Melsungen AG Strengths
    • 10.4.2 B. Braun Melsungen AG Weaknesses
    • 10.4.3 B. Braun Melsungen AG Opportunities
    • 10.4.4 B. Braun Melsungen AG Threats
  • 10.5 Financial and Operational Review
    • 10.5.1 Financial Statements
    • 10.5.2 Financial Ratios
  • 10.6 Locations And Subsidiaries
  • 10.7 Financial Deals Landscape
    • 10.7.1 B. Braun Signs An Agreement With Nipro
    • 10.7.2 B. Braun Enters Into A Licensing Agreement With Chartie Hospital
    • 10.7.3 B. Braun Signs An Agreement With Charite
  • 10.8 Recent Developments
    • 10.8.1 Mar 26, 2008: B. Braun Reports 2007 Results
    • 10.8.2 Oct 25, 2007: B. Braun Melsungen Signs Distribution Agreement With NIPRO
    • 10.8.3 May 25, 2007: B. Braun Melsungen Enters Into Strategic Alliance With Health Robotics
    • 10.8.4 Mar 28, 2007: B. Braun Melsungen Reports 2006 Results
    • 10.8.5 Mar 24, 2007: B. Braun Melsungen To Shut Its Plant In Puerto Rico
    • 10.8.6 Mar 15, 2007: B. Braun Melsungen To Invest In Medical Technology Production
    • 10.8.7 Sep 19, 2005: B. Braun Medical Opens Manufacturing Facility In Suzhou
  • 10.9 B. Braun Melsungen AG Pipeline Products
    • 10.9.1 Coroflex Please
    • 10.9.2 SeQuent Please
• 11 CONMED Corporation Company Profile
  • 11.1 Company Overview
  • 11.2 Business Overview
    • 11.2.1 CONMED Electrosurgery
    • 11.2.2 CONMED Endoscopic Technologies
    • 11.2.3 CONMED Endosurgery
    • 11.2.4 CONMED Linvatec
    • 11.2.5 CONMED Patient Care
    • 11.2.6 Major Products and Services
    • 11.2.7 History
  • 11.3 Value Chain Analysis
    • 11.3.1 Manufacturing
    • 11.3.2 Product Development
    • 11.3.3 Sales and Marketing
  • 11.4 SWOT Analysis
    • 11.4.1 CONMED Corporation Strengths
    • 11.4.2 CONMED Corporation Weaknesses
    • 11.4.3 CONMED Corporation Opportunities
    • 11.4.4 CONMED Corporation Threats
  • 11.5 Financial and Operational Review
    • 11.5.1 Financial Statements
    • 11.5.2 Financial Ratios
    • 11.5.3 Share Holding Structure
  • 11.6 Locations And Subsidiaries
  • 11.7 Financial Deals Landscape
    • 11.7.1 CONMED Signs An Agreement With W.L. Gore & Associates
    • 11.7.2 CONMED Corporation Completes Private Placement
    • 11.7.3 CONMED Acquires Endoscopic Technologies Product Line From C.R. Bard
  • 11.8 Recent Developments
    • 11.8.1 Feb 07, 2008: CONMED Reports Q4 2007 Results
    • 11.8.2 Jan 22, 2008: CONMED To Declare Q4 2007 Results
    • 11.8.3 Jan 22, 2008: CONMED Corporation To Announce Fourth Quarter 2007 Financial Results On February 7, 2008
    • 11.8.4 Jan 04, 2008: CONMED Announces Resignation of Company's CONMED Linvatec Subsidiary President
    • 11.8.5 Jan 04, 2008: CONMED President Resigns
    • 11.8.6 Oct 25, 2007: CONMED Declares Q3 2007 Results
    • 11.8.7 Jul 26, 2007: CONMED Declares Q2 2007 Results
    • 11.8.8 Apr 26, 2007: CONMED Declares Q1 2007 Results
    • 11.8.9 Feb 08, 2007: CONMED Declares Q4 2006 Results
    • 11.8.10 Nov 01, 2006: CONMED Elects New CEO
    • 11.8.11 Oct 26, 2006: CONMED Declares Q3 2006 Results
• 12 Bovie Medical Corporation Company Profile
  • 12.1 Company Overview
  • 12.2 Business Overview
    • 12.2.1 Major Products and Services
    • 12.2.2 History
  • 12.3 Locations And Subsidiaries
  • 12.4 Financial Deals Landscape
    • 12.4.1 Bovie Medical Acquires Assets Of Lican Developments
    • 12.4.2 Bovie Medical And Boston Scientific Enter Into A Distribution Agreement
    • 12.4.3 Bovie Medical And Canady Technology Enter Into A Distribution Agreement
    • 12.4.4 Bovie Medical Acquires Remaining 50% Interest In Its J-Plasma Co-Venture
    • 12.4.5 Bovie Medical And Medline Industries Enter Into Distribution Agreement
    • 12.4.6 Bovie Medical Acquires Technology For Endoscopic Modular Instruments From Henvil
    • 12.4.7 Bovie Medical And Symbol Medical Signs A Distribution Agreement
  • 12.5 Recent Developments
    • 12.5.1 Mar 31, 2008: Bovie Medical Declares Q4 2007 Results
    • 12.5.2 Nov 12, 2007: Bovie Medical Declares Q3 2007 Results
    • 12.5.3 Aug 10, 2007: Bovie Medical Declares Q2 2007 Results
    • 12.5.4 Jun 04, 2007: Bovie Medical Enters Contract With Canady
    • 12.5.5 May 15, 2007: Bovie Medical Declares Q1 2007 Results
    • 12.5.6 Mar 22, 2007: Bovie Medical Declares Q4 2006 Results
  • 12.6 Bovie Medical Corporation Pipeline Products
    • 12.6.1 Modullion
    • 12.6.2 Seal-N-Cut
• 13 Regulation System
  • 13.1 Medical Equipment Approval Process
    • 13.1.1 Pre-market Approval Process
    • 13.1.2 Intended use and Indications for use
    • 13.1.3 Predicate Device
    • 13.1.4 Safe and Effective
    • 13.1.5 Other Category Devices
    • 13.1.6 Post-Market Approval Process
    • 13.1.7 Compliance and Enforcement
    • 13.1.8 Registration Fee
    • 13.1.9 Approval Time
• 14 Pricing and Reimbursement
  • 14.1 Government Policies
  • 14.2 Private Insurance
  • 14.3 Diagnosis Related Groups (DRG)
• 15 Distribution Structure
  • 15.1 Distribution Structure
• 16 APPENDIX
  • 16.1 Global Markets Direct Research Methodology
  • 16.2 Coverage
  • 16.3 Secondary Research
  • 16.4 Primary Research
  • 16.5 Models
  • 16.6 Forecasts
  • 16.7 Expert Panels
  • 16.8 Contact Us
  • 16.9 Disclaimer